Tech Company Financing Transactions
Onchilles Pharma Funding Round
InVivium Capital, Kennedy Lewis Investment Management and Lincoln Park Capital joined a $25 million Series A funding round for Onchilles Pharma. The round was announced on 11/7/2025.
Transaction Overview
Company Name
Announced On
11/7/2025
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9880 Campus Point Dr. 420
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Onchilles Pharma was founded on breakthrough research that was the first to describe that human neutrophils release a major anticancer protein, called ELANE, that broadly and selectively activates cell death pathways in cancer cells. This fundamental pathway of the innate immune system has the potential for universal anti-cancer activity, independent of genetic mutation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Court Turner
Co-Founder
Lev Becker
Browse more venture capital transactions:
Prev: 11/7/2025: Comet Software venture capital transaction
Next: 11/7/2025: Upward venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs